Fulgent Genetics, Inc. Q1 FY2025 Earnings Call

Fulgent Genetics, Inc. (FLGT)

Earnings Call FY2025 Q1 Call date: 2025-05-02 Concluded

Quarter scorecard

Revenue

$73.46M

+13.9% YoY

Gross margin

38.6%

+4.3 pp YoY

Net income

-$11.53M

Laboratory Services $73.46M

+13.9%

Therapeutic Development $0

Buybacks

$8.68M

Shares repurchased

500,000